Targeting Language-specific and Executive-control Networks With Transcranial Direct Current Stimulation in Logopenic Var
RecruitingNCT03887481Phase: NAStarted 2022-10-15
Summary
AD afflicts over 5.5. million Americans and is one of the most expensive diseases worldwide. In AD the variant in which language functions are most affected are referred to as 'logopenic variant Prima
Eligibility
Sex
ALL
Min Age
50 Years
Max Age
80 Years
Locations
Johns Hopkins HospitalBaltimore, Maryland, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT03887481